MedPath

天津药物研究院药业有限责任公司

Ownership
-
Established
1994-08-18
Employees
-
Market Cap
-
Website
www.cnpha.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

67

NMPA:67

Drug Approvals

Pentazocine Injection

Product Name
喷他佐辛注射液
Approval Number
国药准字H20253995
Approval Date
Apr 22, 2025
NMPA

Rivaroxaban Tablets

Product Name
利伐沙班片
Approval Number
国药准字H20234023
Approval Date
Aug 8, 2023
NMPA

Ambroxol Hydrochloride Granules

Product Name
盐酸氨溴索颗粒
Approval Number
国药准字H20090026
Approval Date
Aug 7, 2023
NMPA

Ambroxol Hydrochloride Granules

Product Name
盐酸氨溴索颗粒
Approval Number
国药准字H20123026
Approval Date
Aug 7, 2023
NMPA

Tenofovir Alafenamide Fumarate Tablets

Product Name
富马酸丙酚替诺福韦片
Approval Number
国药准字H20233581
Approval Date
May 19, 2023
NMPA

Argatroban Injection

Product Name
阿加曲班注射液
Approval Number
国药准字H20223457
Approval Date
Feb 21, 2023
NMPA

Rivaroxaban Tablets

Product Name
利伐沙班片
Approval Number
国药准字H20233194
Approval Date
Feb 14, 2023
NMPA

Lomefloxacin Aspartate Injection

Product Name
门冬氨酸洛美沙星注射液
Approval Number
国药准字H20063647
Approval Date
Aug 4, 2020
NMPA

Buprenorphine Hydrochloride Injection

Product Name
盐酸丁丙诺啡注射液
Approval Number
国药准字H12020275
Approval Date
Aug 4, 2020
NMPA

Ramosetron Hydrochloride Injection

Product Name
盐酸雷莫司琼注射液
Approval Number
国药准字H20054781
Approval Date
Aug 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.